0.50 / AMA PRA Category 1 CreditTM 0.50 / CNE Contact Hour 0.50 / CE for Pharmacists (0.05 CEU)
This activity is provided by Haymarket Medical Education for physician credit. This activity is provided by AKH Inc., Advancing Knowledge in Healthcare for nursing contact hours. This activity is provided by AKH Inc., Advancing Knowledge in Healthcare for pharmacy contact hours.
Supported by an educational grant from the Bristol-Myers Squibb and Pfizer Alliance.
Thrombotic events including venous thromboembolism (VTE) are very common among patients with cancer. Despite the known risks of VTE and the particularly harmful impact it may have on patients with malignancies, chemoprophylaxis against thrombotic events remains underutilized in this patient population. For optimal outcomes, it is critical that clinicians who treat patients with malignancies are aware of the most recent evidence-based information on VTE treatment and prevention and know how to best apply updated information in routine clinical practice.
In this activity, Kenneth Bauer, MD, and Alok Khorana, MD, review some of the key concepts in the prevention and treatment of VTE among individuals with cancer, including the need to stratify patients according to their individual level of risk. The expert faculty also discuss some of the key pearls from recently updated guidelines for VTE management and review available options for anticoagulation and the need to tailor therapy according to the clinical characteristics and desires of each patient.
Hematologists-oncologists, physicians, nurse practitioners (NPs), physician assistants (PAs), hospitalists, emergency room physicians, oncology nurses, and specialty pharmacists (includes hospital pharmacists and pharmacy specialties such as associate directors, pharmacy directors, clinical coordinators, clinical pharmacist generalists, and clinical pharmacist specialists)
At the conclusion of this activity, participants should be better able to:
Describe the key concepts in the prevention and treatment of venous thromboembolism (VTE) in patients with cancer, including the need to stratify patients according to their individual level of risk
Apply updated evidence-based guideline recommendations for the prevention and treatment of cancer-related VTE in routine clinical practice
Employ individualized anticoagulation regimens for prevention and treatment of VTE in patients with cancer, based on the unique needs and characteristics of each patient
Accredited Provider Conflict Of Interest Disclosure Policy
In accordance with the ACCME Standards for Commercial Support, HME and AKH require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. HME and AKH resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational activities.
Kenneth A. Bauer, MD Professor of Medicine Harvard Medical School Member, Hematology-Oncology Division Beth Israel Deaconess Medical Center Boston, MA
Dr. Bauer receives consulting fees from Janssen Pharmaceuticals.
Alok A. Khorana, MD, FACP, FASCO Professor of Medicine Cleveland Clinic Lerner College of Medicine Case Western Reserve University Director, Gastrointestinal Malignancies Program Cleveland Clinic Cleveland, OH
Dr. Khorana receives consulting fees from Bayer, Janssen Pharmaceuticals, Pfizer Inc., and Sanofi.
Pharmacy Content Reviewer and Disclosure Dorothy Duffy, RPh, BS Pharmacy Pharmacist Van Houton Pharmacy Clifton, NJ
Ms. Duffy has no relevant financial relationships to disclose.
Accredited Provider Disclosure
Krista Sierra and Lori Marrese of Haymarket Medical Education, AKH, and Dorothy Caputo, MA, BSN, RN, Lead Nurse Planner of AKH Inc., Advancing Knowledge in Healthcare have no relevant financial relationships to disclose.
AMA PRA Category 1 Credit(s)TM
Haymarket Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Haymarket Medical Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)TM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Contact Hour(s)
AKH Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity is awarded 0.50 contact hour.
CE for Pharmacists
AKH Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
AKH Inc., Advancing Knowledge in Healthcare approves this knowledge-based activity for 0.50 contact hour (0.05 CEU). UAN 0077-9999-19-036-H04-P. Initial release date: 6/14/2019.
If you claim CE for Pharmacy credit, you will be prompted to include your National Association of Boards of Pharmacy (NABP) number and date/month of birth. This information must be included in order for you to receive credit.
Additional Credit Information
Physician Assistant Continuing Education AAPA accepts certificates of participation for educational activities approved for AMA PRA Category 1 CreditsTM from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 0.50 Category 1 Credit for completing this activity.
Nurse Practitioner Continuing Education AANPCP accepts certificates of participation for educational activities approved for AMA PRA Category 1 CreditsTM from organizations accredited by ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
Disclosure of Unlabeled Use
This CME/CE/ACPE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE/ACPE activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient's medical condition.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Haymarket Medical Education, AKH Inc., Advancing Knowledge in Healthcare, or the Bristol-Myers Squibb and Pfizer Alliance. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.